Akses terbuka Jurnal SINTA 1
Effectivity of Erythropoietin Alpha Compared to Erythropoietin Beta in Patients with Chronic Kidney Disease-Anemia on Hemodialysis
Folia Medica Indonesiana · Vol. 55 No. 2 (2019) · hlm. 82–82
- ISSN
- 2355-8393, 2599-056X
- Terbit
- 2019-07-12
- Penerbit
- Airlangga University
- Bahasa
- en
Abstrak
Anemia in patient with chronic kidney disease could cause a lot of complication. The first line therapy of this condition is by treating with erythropoiesis-stimulating agents (ESA) or called erythropoietin. The erythropoietin alpha and beta were two types of the human recombinant erythropoietin that are usually used in Indonesia. The aim of this study was to determine the effectivity of erythropoietin alpha compared to erythropoietin beta especially in haemoglobin and haematocrit level. This prospective observational study was conducted in March – September 2016. The inclusion criteria were CKD stage 5 patients with a minimum of 3 months of regular hemodialysis, Hb 20% and FS > 200ng/mL. The methology of this study had been approved by the Health Research Ethics Committee of the Bhayangkara H.S. Samsoeri Mertojoso Hospital, Surabaya. Patients received 2000 IU subcutaneous erythropoietin twice a week on both groups. Blood sample was withdrawn in pre-treatment and after 4 weeks of post erythropoietin therapy treatment for measurement of haemoglobin and haematocrit. Target for this erythropoietin therapy are increase of Hb 0.5 – 1.5 g/dL (not to exceed 12 g/dL) and increase of Hct level 2 – 4 % in 4 weeks. Based on the inclusion criteria, there were 20 patients in this study (10 patient each of both erythropoietin alpha either beta group) that consist of 7 women and 13 men. After the treatment, the mean of increased haemoglobin level for erythropoietin alpha group was 1.28 ± 0.80 g/dL (p=0.001) and erythropoietin beta was 0.37 ± 0.95 g/dL (p=0.254). The mean of increased haematocrit level for erytropoietin alpha group was 3.56 ± 3.46 % (p=0.010) and erythropoietin beta was 1.34 ± 2.71 % (p=0.152). In comparison of haemoglobin and haematocrit achievement in both groups showed that erythropoietin alpha gave better achievement in haemoglobin parameter (p=0.033), but there were no differences in both groups on haematocrit parameters (p=0.127).
Kata kunci
Jaringan kolaborasi para penulis
25 penulis · 59 tautan kepenulisan bersama · 8 lintas organisasi
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
- Universitas Airlangga
- State University of Makassar
- Afiliasi tidak diketahui
- Organisasi berbeda
- Organisasi sama
- Afiliasi tidak diketahui
- Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
| Rekan penulis | Organisasi | Artikel bersama |
|---|---|---|
| Mahardian Rahmadi | Universitas Airlangga | 2 |
| Junaidi Khotib | Universitas Airlangga | 2 |
| Eddy Rahardjo | Universitas Airlangga | 2 |
| Dewi Wara Shinta | Universitas Airlangga | 2 |
| Andi Bulqiah Nur | State University of Makassar | 1 |
| Moch Yusuf | Universitas Airlangga | 1 |
| Yulistiani | Universitas Airlangga | 1 |
| Wulida Nuril Fajriyah | State University of Makassar | 1 |
| Zam Zami Jauhari | Universitas Airlangga | 1 |
| Diyah Wahyuni | Universitas Airlangga | 1 |
| Ramadi Satryo Wicaksono | Afiliasi tidak diketahui | 1 |
| Abdul Kadir Jaelani | Afiliasi tidak diketahui | 1 |
| Vini Siane Tanaem | Universitas Airlangga | 1 |
| Yulistiani Yulistiani | Universitas Airlangga | 1 |
| Mida Purwiningtyas | Universitas Airlangga | 1 |
| Bayu Dharma Santi | Afiliasi tidak diketahui | 1 |
| Sarah Puspita Atmaja | Universitas Airlangga | 1 |
| Dwi Hari Susilo | Universitas Airlangga | 1 |
| Ria Fitrah Arfiani | Universitas Airlangga | 1 |
| Agung Dwi Wahyu Widodo | Universitas Airlangga | 1 |
| Muhammad Thariq Nadhafi | Afiliasi tidak diketahui | 1 |
| Bambang Wahjuprajitno | Afiliasi tidak diketahui | 1 |
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.